Neurogene clinical trials we track

Check company identity source

Phase 3 1 trial

TrialDrugs studiedStatusPrimary completion
A Novel, Regulated Gene Therapy (NGN-401) Study for Females With Rett SyndromeNCT05898620NGN-401Active not recruiting2029-12Estimated

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters